• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝星状细胞激活的机制。

Mechanisms of hepatic stellate cell activation.

机构信息

Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, Box 1123, New York, New York 10029, USA.

Research Division, Mitsubishi Tanabe Pharma Corporation, 2-2-50, Kawagishi, Toda-shi, Saitama 335-8505, Japan.

出版信息

Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411. doi: 10.1038/nrgastro.2017.38. Epub 2017 May 10.

DOI:10.1038/nrgastro.2017.38
PMID:28487545
Abstract

Hepatic fibrosis is a dynamic process characterized by the net accumulation of extracellular matrix resulting from chronic liver injury of any aetiology, including viral infection, alcoholic liver disease and NASH. Activation of hepatic stellate cells (HSCs) - transdifferentiation of quiescent, vitamin-A-storing cells into proliferative, fibrogenic myofibroblasts - is now well established as a central driver of fibrosis in experimental and human liver injury. Yet, the continued discovery of novel pathways and mediators, including autophagy, endoplasmic reticulum stress, oxidative stress, retinol and cholesterol metabolism, epigenetics and receptor-mediated signals, reveals the complexity of HSC activation. Extracellular signals from resident and inflammatory cells including macrophages, hepatocytes, liver sinusoidal endothelial cells, natural killer cells, natural killer T cells, platelets and B cells further modulate HSC activation. Finally, pathways of HSC clearance have been greatly clarified, and include apoptosis, senescence and reversion to an inactivated state. Collectively, these findings reinforce the remarkable complexity and plasticity of HSC activation, and underscore the value of clarifying its regulation in hopes of advancing the development of novel diagnostics and therapies for liver disease.

摘要

肝纤维化是一种动态过程,其特征是由于任何病因(包括病毒感染、酒精性肝病和 NASH)引起的慢性肝损伤导致细胞外基质的净积累。肝星状细胞(HSCs)的激活-静止的、储存维生素 A 的细胞向增殖性、纤维生成性肌成纤维细胞的转分化-现已被充分确立为实验性和人类肝损伤中纤维化的主要驱动因素。然而,包括自噬、内质网应激、氧化应激、视黄醇和胆固醇代谢、表观遗传学和受体介导的信号在内的新途径和介质的不断发现,揭示了 HSC 激活的复杂性。包括巨噬细胞、肝细胞、肝窦内皮细胞、自然杀伤细胞、自然杀伤 T 细胞、血小板和 B 细胞在内的驻留细胞和炎症细胞的细胞外信号进一步调节 HSC 的激活。最后,HSC 清除途径已得到极大澄清,包括凋亡、衰老和恢复到无活性状态。总之,这些发现强化了 HSC 激活的显著复杂性和可塑性,并强调了阐明其调控的重要性,以期推进肝病新诊断和治疗方法的发展。

相似文献

1
Mechanisms of hepatic stellate cell activation.肝星状细胞激活的机制。
Nat Rev Gastroenterol Hepatol. 2017 Jul;14(7):397-411. doi: 10.1038/nrgastro.2017.38. Epub 2017 May 10.
2
[Mechanisms of hepatic stellate cell activation as a therapeutic target for the treatment of non-alcoholic steatohepatitis].[肝星状细胞激活机制作为非酒精性脂肪性肝炎治疗的靶点]
Nihon Yakurigaku Zasshi. 2019;154(4):203-209. doi: 10.1254/fpj.154.203.
3
Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.肝星状细胞中的分子相互作用:细胞凋亡、衰老以及表型逆转作为调节肝纤维化的细胞关联机制
Cell Biol Int. 2017 Sep;41(9):946-959. doi: 10.1002/cbin.10790. Epub 2017 Jul 20.
4
Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.肝星状细胞与肝纤维化中周围细胞的串扰。
Int Immunopharmacol. 2021 Oct;99:108051. doi: 10.1016/j.intimp.2021.108051. Epub 2021 Aug 18.
5
Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview.肝星状细胞在代谢紊乱发展过程中的作用——分子概述。
Pharmacol Res. 2021 Aug;170:105739. doi: 10.1016/j.phrs.2021.105739. Epub 2021 Jun 23.
6
Wnt signaling in liver fibrosis: progress, challenges and potential directions.Wnt 信号通路在肝纤维化中的作用:进展、挑战与潜在方向。
Biochimie. 2013 Dec;95(12):2326-35. doi: 10.1016/j.biochi.2013.09.003. Epub 2013 Sep 13.
7
Recent advancement of molecular mechanisms of liver fibrosis.肝纤维化分子机制的最新进展
J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):512-8. doi: 10.1002/jhbp.245. Epub 2015 Apr 13.
8
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.胰岛素抵抗促进非酒精性脂肪性肝病中赖氨酰氧化酶样蛋白2的诱导表达及纤维化积累。
Clin Sci (Lond). 2017 Jun 7;131(12):1301-1315. doi: 10.1042/CS20170175. Print 2017 Jun 1.
9
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.脂多糖诱导的肿瘤坏死因子-α因子介导非酒精性脂肪性肝病中的促炎和促纤维化模式。
Oncotarget. 2015 Dec 8;6(39):41434-52. doi: 10.18632/oncotarget.5163.
10
Cell death and fibrogenesis.细胞死亡与纤维化。
Semin Liver Dis. 2010 Aug;30(3):226-31. doi: 10.1055/s-0030-1255352. Epub 2010 Jul 21.

引用本文的文献

1
Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease.营养素作为代谢功能障碍相关脂肪性肝病中的表观遗传调节剂。
World J Hepatol. 2025 Aug 27;17(8):108182. doi: 10.4254/wjh.v17.i8.108182.
2
Vitamin A toxicity and hepatic pathology: A comprehensive review.维生素A毒性与肝脏病理学:全面综述
World J Hepatol. 2025 Aug 27;17(8):107738. doi: 10.4254/wjh.v17.i8.107738.
3
Phenolic-rich extracts of Teucrium oliverianum confer protection against thioacetamide-induced liver fibrosis in rats: Insights from metabolomics, biochemical and histopathological analysis.

本文引用的文献

1
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy.未折叠蛋白反应的 XBP1 分支通过自噬诱导肝星状细胞的纤维生成活性。
Sci Rep. 2016 Dec 20;6:39342. doi: 10.1038/srep39342.
2
p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.通过与维生素D受体结合,p62/SQSTM1抑制肝星状细胞活性、纤维化和肝癌。
Cancer Cell. 2016 Oct 10;30(4):595-609. doi: 10.1016/j.ccell.2016.09.004.
3
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
绵毛香科植物富含酚类提取物对硫代乙酰胺诱导的大鼠肝纤维化具有保护作用:代谢组学、生化和组织病理学分析的见解
PLoS One. 2025 Sep 2;20(9):e0330595. doi: 10.1371/journal.pone.0330595. eCollection 2025.
4
Comprehensive Genetic and Molecular Characterization Confirms Hepatic Stellate Cell Origin of the Immortal Col-GFP HSC Line.全面的基因和分子特征分析证实了永生化Col-GFP肝星状细胞系的肝星状细胞起源。
Int J Mol Sci. 2025 Aug 11;26(16):7764. doi: 10.3390/ijms26167764.
5
Targeting Lipophagy in Liver Diseases: Impact on Oxidative Stress and Steatohepatitis.靶向肝脏疾病中的脂质自噬:对氧化应激和脂肪性肝炎的影响
Antioxidants (Basel). 2025 Jul 24;14(8):908. doi: 10.3390/antiox14080908.
6
The Impact of Hybrid Bionanomaterials Based on Gold Nanoparticles on Liver Injury in an Experimental Model of Thioacetamide-Induced Hepatopathy.基于金纳米颗粒的杂化生物纳米材料对硫代乙酰胺诱导的肝病实验模型中肝损伤的影响
Biomolecules. 2025 Jul 24;15(8):1068. doi: 10.3390/biom15081068.
7
Protective effects of melatonin and naringenin against acitretin induced hepatotoxicity via modulation of oxidative stress and inflammatory signaling.褪黑素和柚皮素通过调节氧化应激和炎症信号通路对阿维A诱导的肝毒性的保护作用
Sci Rep. 2025 Aug 27;15(1):31629. doi: 10.1038/s41598-025-16740-9.
8
Disturbance of cytoskeleton induced by ligustilide promotes hepatic stellate cell senescence and ameliorates liver fibrosis.川芎嗪诱导的细胞骨架紊乱促进肝星状细胞衰老并改善肝纤维化。
Theranostics. 2025 Jul 24;15(16):8049-8067. doi: 10.7150/thno.108869. eCollection 2025.
9
Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis.芒柄花黄素在肝硬化门静脉高压症中的治疗潜力:调节肝纤维化、巨噬细胞极化和淋巴管生成
Front Immunol. 2025 Aug 7;16:1571007. doi: 10.3389/fimmu.2025.1571007. eCollection 2025.
10
Taurochenodeoxycholic acid as a sensitive stratification marker for HBV-associated hepatic cirrhosis status has a hepatoprotective effect.牛磺鹅去氧胆酸作为乙肝相关肝硬化状态的敏感分层标志物具有肝脏保护作用。
Sci Rep. 2025 Aug 20;15(1):30547. doi: 10.1038/s41598-025-16348-z.
法尼醇 X 受体激动剂奥贝胆酸可减少大鼠中毒性肝硬化模型中的肝脏炎症和纤维化。
Sci Rep. 2016 Sep 16;6:33453. doi: 10.1038/srep33453.
4
Epigenetics in liver disease: from biology to therapeutics.肝病中的表观遗传学:从生物学到治疗学
Gut. 2016 Nov;65(11):1895-1905. doi: 10.1136/gutjnl-2015-311292. Epub 2016 Sep 13.
5
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.PAK 蛋白和整合素 β1 下游的 YAP-1 信号在肌成纤维细胞中促进肝纤维化。
Nat Commun. 2016 Aug 18;7:12502. doi: 10.1038/ncomms12502.
6
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis.双重CCR2/CCR5拮抗剂西尼莫德在肝纤维化和肾纤维化动物模型中的抗纤维化作用
PLoS One. 2016 Jun 27;11(6):e0158156. doi: 10.1371/journal.pone.0158156. eCollection 2016.
7
Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells.Wnt信号通路通过稳定MeCP2蛋白来抑制肝星状细胞激活过程中的PPAR-γ。
PLoS One. 2016 May 23;11(5):e0156111. doi: 10.1371/journal.pone.0156111. eCollection 2016.
8
Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis.外泌体介导的星状细胞中 toll 样受体 3 的激活刺激肝纤维化中 γδ T 细胞产生白细胞介素 17。
Hepatology. 2016 Aug;64(2):616-31. doi: 10.1002/hep.28644. Epub 2016 Jun 29.
9
Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in mice.肝星状细胞上的白细胞介素-15受体α调节小鼠肝纤维化的发生。
J Hepatol. 2016 Aug;65(2):344-353. doi: 10.1016/j.jhep.2016.04.020. Epub 2016 May 3.
10
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.LATS2肿瘤抑制因子抑制固醇调节元件结合蛋白并抑制肝脏胆固醇积累。
Genes Dev. 2016 Apr 1;30(7):786-97. doi: 10.1101/gad.274167.115. Epub 2016 Mar 24.